Achieve Life Sciences free cash flow ACHV

Cash from operations less capital spending, by quarter and over the last twelve months, from 2010.

Achieve Life Sciences' twelve-month free cash flow can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q4 FY23, it was −$4.4M.

Free cash flow over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	Free cash flow	On a year earlier	Last 12 months
Q4 FY23	Dec 31, 2023	−$4.4M	n/a	n/a
Q4 FY20	Dec 31, 2020	−$2.5M	n/a	−$13.5M
Q3 FY20	Sep 30, 2020	−$4.3M	n/a	−$14.4M
Q2 FY20	Jun 30, 2020	−$2.2M	n/a	−$13.2M
Q1 FY20	Mar 31, 2020	−$4.5M	n/a	−$14.8M
Q4 FY19	Dec 31, 2019	−$3.4M	n/a	−$15.3M
Q3 FY19	Sep 30, 2019	−$3.1M	n/a	−$15.4M
Q2 FY19	Jun 30, 2019	−$3.8M	n/a	−$15.3M
Q1 FY19	Mar 31, 2019	−$4.9M	n/a	n/a
Q4 FY18	Dec 31, 2018	−$3.6M	n/a	n/a
Q3 FY18	Sep 30, 2018	−$3M	n/a	n/a
Q2 FY17	Jun 30, 2017	−$18K	n/a	−$7.4M

Companies in Medical - Diagnostics & Research nearest Achieve Life Sciences' size, closest first, today.

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.